Indication

Congenital neurosyphilis

Congenital neurosyphilis is a severe complication of congenital syphilis resulting from the vertical transplacental transmission of the spirochete bacterium *Treponema pallidum* from an infected mother to the developing fetus. Read more about Congenital neurosyphilis

15 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Congenital neurosyphilis therapies.

Showing 10–15 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Congenital neurosyphilis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Congenital neurosyphilis.

Congenital neurosyphilis is a severe complication of congenital syphilis resulting from the vertical transplacental transmission of the spirochete bacterium *Treponema pallidum* from an infected mother to the developing fetus.

It affects the central nervous system of neonates, infants, and older children, potentially manifesting in either early or late stages of the disease.

Defining pathophysiologic and clinical features include spirochetal invasion of the meninges and cerebral vasculature, which may present as aseptic meningitis, cranial nerve palsies, seizures, developmental delay, or hydrocephalus.

Diagnosis is characterized by abnormal cerebrospinal fluid findings, including elevated white blood cell counts, elevated protein concentrations, or a reactive cerebrospinal fluid non-treponemal antibody test.

Personalize your experience

Follow Congenital neurosyphilis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it